Featured Speakers

Keynotes

Luncheon Keynote

Robert J. Hugin
Chairman and CEO
Celgene Corporation

Morning Keynotes

Andre Wyss
US Country Head, President
Novartis Corporation and
President
Novartis Pharmaceuticals Corporation

John F. Crowley
Chairman and CEO
Amicus Therapeutics, Inc.

Afternoon Keynote

Tony Gibney
Managing Director
Leerink Swann LLC

Reception, Dinner and Fireside Chat on the Evening of Thursday, October 3

(By invitation only) 

Dominic J. Caruso
Vice President of Finance and CFO
Johnson & Johnson

Presenting Companies

Will Lewis
President and CEO
Insmed Incorporated

David Pearson, Ph.D.
President
Thrombogenics, Inc.

Spiro Rombotis
President and CEO
Cyclacel Pharmaceuticals, Inc.

Panelists and Moderators

In the Trenches with Tranches: Financing Strategies for Growth

Lorenzo Pellegrini, Ph.D.
Partner
Care Capital, LLC

Stuart Peltz, Ph.D.
CEO
PTC Therapeutics, Inc.

Chris Tyrrell
CEO
OfferBoard

Michael Wells
Managing Director
Princeton Biopharma Capital Partners LLC

Moderator:
James Marino, Esq.
Partner
Dechert LLP

Inside Outsourcing

John Barry
Global Head, Vendor Management for Development
Merck & Co., Inc.

Sally Macaluso
Vice President, Janssen R&D Procurement
Johnson & Johnson

Ralph Marcello
Principal
Deloitte

Raymond Hill
President
inVentiv Health Clinical

John Watson
Corporate Senior Vice President, President, Strategic Partnering and Chief Commercial Officer
Covance Inc.

Moderator:
John Fraher
President
Aptalis Pharma

How Wide is the Crack in the IPO Window?

Kenneth I. Moch
President and CEO
Chimerix, Inc.

Christian S. Schade
Executive Vice President and CFO
Omthera Pharmaceuticals, Inc.

Panna Sharma
President and CEO
Cancer Genetics, Inc.

Moderator:
Hector G. Calzada, Jr.
Managing Director
Deloitte Corporate Finance LLC

Billion Dollar Babies

Anthony Marucci
Founder, President and CEO
Celldex Therapeutics , Inc.

Francois Nader, M.D.
President and CEO
NPS Pharmaceuticals, Inc.

Glenn Sblendorio
President and CFO
The Medicines Company

Moderator:
Julie Kampf
CEO and President
JBK Associates International